Protective effect of bicyclol against acute fatty liver induced by tetracycline in mice

Yaoxue Xuebao

Volumn 43, Issue 1, 2008, Pages 23-28

  Tang, Tao ^a   Li, Yan ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Bicyclol; Fatty liver; Tetracycline

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BICYCLOL; BIPHENYL DERIVATIVE; CHOLESTEROL; FATTY ACID; GLUTATHIONE; MALONALDEHYDE; PROTECTIVE AGENT; TETRACYCLINE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FATTY LIVER; INSTITUTE FOR CANCER RESEARCH MOUSE; LIPID PEROXIDATION; LIVER; LIVER MITOCHONDRION; MALE; METABOLISM; MOUSE; PATHOLOGY; RANDOMIZATION;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BIPHENYL COMPOUNDS; CHOLESTEROL; CHOLESTEROL, VLDL; FATTY ACIDS; FATTY LIVER; GLUTATHIONE; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; MITOCHONDRIA, LIVER; PROTECTIVE AGENTS; RANDOM ALLOCATION; TETRACYCLINE; TRIGLYCERIDES;

EID: 38849115859     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Yu A, Dai Y. Drug-induced hepatitis [J]. J Pharm Pract, 2003,21:71-73.
2. Kaplowitz N. Drug-induced liver disorders: implications for drug development and regulation [J]. Drug Saf, 2001,24:483-490.
3. Fan JG, Zeng MD. Fatty Liver [M]. Shanghai: Fudan University Press, 2000:43-44.
4. 4-induced liver injury in mice [J]. Liver Int, 2005,25:872-879.
5. Wang HP, Li Y. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice [J]. Eur J Pharmacol, 2006,534:194-201.
6. Ellman GL. Tissue sulfhydryl groups [J]. Arch Biochem Biophys, 1959,82:70-77.
7. Berson A, Renault S, Letteron P, et al. Uncoupling of rat and human mitochondria: a possible explanation for tacrine-induced liver dysfunction [J]. Gastroenterology, 1996,110:1878-1890.
8. Letteron P, Sutton A, Mansouri A, et al. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice [J]. Hepatology, 2003,38:133-140.
9. Duerden JM, Gibbons GF. Secretion and storage of newly synthesized hepatic triacylglycerol fatty acids in vivo in different nutritional states and in diabetes [J]. Biochem J, 1988,255:929-935.
10. Labbe G, Fromenty B, Freneaux E, et al. Effects of various tetracycline derivatives on in vitro and in vivo beta-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice [J]. Biochem Pharmacol, 1991,41:638-641.
11. Deboyser D, Goethals F, Krack G, et al. Investigation into the mechanism of tetracycline-induced steatosis: study in isolated hepatocytes [J]. Toxicol Appl Pharmacol, 1989,97:473-479.
12. Breen KJ, Schenker S, Heimberg M. Fatty liver induced by tetracycline in the rat. Dose-response relationships and effect of sex [J]. Gastroenterology, 1975,69:714-723.
13. Amacher DE, Martin BA. Tetracycline-induced steatosis in primary canine hepatocyte cultures [J]. Fundam Appl Toxicol, 1997,40:256-263.
14. Goldberg IJ. Association of plasma lipoprotein with postheparin lipase activities [J]. J Clin Invest, 1986,78:1523-1528.
15. Letteron P, Sutton A, Mansouri A, et al. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice [J]. Hepatology, 2003,38:133-140.
16. Fromenty B, Pessayre D. Inhibition of mitochondrial β-oxidation as a mechanism of hepatotoxicity [J]. Pharmacol Ther, 1995,67:101-154.
17. Letteron P, Fromenty B, Terris B, et al. Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice [J]. J Hepatol, 1996,24:200-208.